IPHA

Innate Pharma
IPHA

9 hedge funds and large institutions have $255K invested in Innate Pharma in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$869
2
+$828

Top Sellers

1
-$161K
2
-$17.4K
3
-$9.01K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$143K
2
$80.1K
3
$21.9K
4
$6.46K
5
$1.25K
6
$1K
7
$828
8
$368
9
$187